
Genfit S.A (GNFT) | Financial Analysis & Statements
Genfit S.A. | Mid-cap | Healthcare
Genfit S.A. | Mid-cap | Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2023Income Metrics
Revenue
14.3M
Balance Sheet Metrics
Total Assets
151.4M
Total Liabilities
82.2M
Shareholders Equity
69.2M
Debt to Equity
1.19
Cash Flow Metrics
Revenue & Profitability Trend
Genfit S.A Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 67.0M | 28.6M | 20.2M | 80.1M | 765.0K |
Cost of Goods Sold | 300.0K | 341.0K | 251.0K | 162.0K | 202.0K |
Gross Profit | 66.7M | 28.2M | 19.9M | 79.9M | 563.0K |
Gross Margin % | 99.6% | 98.8% | 98.8% | 99.8% | 73.6% |
Operating Expenses | |||||
Research & Development | 47.4M | 46.7M | 35.9M | 35.3M | 59.2M |
Selling, General & Administrative | 8.7M | 8.0M | 7.3M | 8.2M | 18.2M |
Other Operating Expenses | 7.0M | 307.0K | 3.9M | 3.6M | 236.0K |
Total Operating Expenses | 63.1M | 55.1M | 47.1M | 47.0M | 77.6M |
Operating Income | 3.2M | -27.2M | -27.3M | 32.4M | -77.5M |
Operating Margin % | 4.8% | -95.1% | -135.3% | 40.4% | -10,131.9% |
Non-Operating Items | |||||
Interest Income | 1.8M | 1.7M | 137.0K | 274.0K | 1.4M |
Interest Expense | 4.7M | 4.6M | 4.4M | 5.0M | 11.8M |
Other Non-Operating Income | 791.0K | 72.0K | 7.2M | 6.2M | -13.9M |
Pre-tax Income | 1.8M | -28.5M | -23.8M | 69.5M | -101.6M |
Income Tax | 340.0K | 380.0K | -116.0K | 2.2M | -428.0K |
Effective Tax Rate % | 18.4% | 0.0% | 0.0% | 3.2% | 0.0% |
Net Income | 1.5M | -28.9M | -23.7M | 67.3M | -101.2M |
Net Margin % | 2.2% | -101.2% | -117.4% | 84.0% | -13,231.5% |
Key Metrics | |||||
EBITDA | 7.5M | -22.3M | -24.8M | 71.0M | -72.4M |
EPS (Basic) | - | €-0.58 | €-0.48 | €1.51 | €-2.60 |
EPS (Diluted) | - | €-0.58 | €-0.48 | €1.23 | €-2.60 |
Basic Shares Outstanding | - | 49700223 | 49414583 | 44739756 | 38858617 |
Diluted Shares Outstanding | - | 49700223 | 49414583 | 44739756 | 38858617 |
Income Statement Trend
Genfit S.A Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 81.8M | 77.8M | 136.0M | 258.8M | 171.0M |
Short-term Investments | - | 0 | 4.6M | 0 | - |
Accounts Receivable | 2.1M | 18.5M | 3.2M | 7.2M | 793.0K |
Inventory | 4.0K | 4.0K | 4.0K | 4.0K | 4.0K |
Other Current Assets | 1.0K | 1.0K | 1.0K | - | - |
Total Current Assets | 92.8M | 113.1M | 158.5M | 268.1M | 184.7M |
Non-Current Assets | |||||
Property, Plant & Equipment | 5.2M | 5.3M | 6.5M | 6.3M | 9.1M |
Goodwill | 48.0M | 48.8M | 44.0M | 174.0K | 297.0K |
Intangible Assets | 48.0M | 48.8M | 44.0M | 174.0K | 297.0K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 353.0K | 530.0K | 0 | 517.0K | 688.0K |
Total Non-Current Assets | 58.7M | 60.8M | 57.1M | 13.6M | 13.4M |
Total Assets | 151.4M | 173.9M | 215.5M | 281.7M | 198.1M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 13.4M | 10.4M | 8.6M | 12.3M | 20.3M |
Short-term Debt | 56.6M | 7.9M | 5.1M | 2.2M | 4.3M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | -1.0K | - | - | - | -1.0K |
Total Current Liabilities | 75.2M | 38.5M | 39.4M | 62.8M | 31.1M |
Non-Current Liabilities | |||||
Long-term Debt | 5.6M | 62.3M | 70.2M | 72.0M | 181.3M |
Deferred Tax Liabilities | 145.0K | 455.0K | 510.0K | 602.0K | 767.0K |
Other Non-Current Liabilities | - | - | 1.0K | 2.0K | - |
Total Non-Current Liabilities | 7.0M | 67.4M | 81.6M | 99.8M | 183.5M |
Total Liabilities | 82.2M | 105.9M | 121.0M | 162.6M | 214.5M |
Equity | |||||
Common Stock | 12.5M | 12.5M | 12.5M | 12.5M | 9.7M |
Retained Earnings | -390.6M | -390.8M | -361.3M | -337.8M | -405.1M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 69.2M | 68.0M | 94.5M | 119.1M | -16.4M |
Key Metrics | |||||
Total Debt | 62.1M | 70.2M | 75.3M | 74.2M | 185.7M |
Working Capital | 17.6M | 74.6M | 119.1M | 205.3M | 153.6M |
Balance Sheet Composition
Genfit S.A Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 1.5M | -28.9M | -23.7M | 67.3M | -101.2M |
Depreciation & Amortization | 1.7M | 1.7M | 1.8M | 2.7M | 3.6M |
Stock-Based Compensation | 610.0K | 578.0K | 245.0K | 470.0K | 1.2M |
Working Capital Changes | 8.4M | -27.8M | -54.8M | 59.7M | -11.1M |
Operating Cash Flow | 15.5M | -54.5M | -72.3M | 101.5M | -99.5M |
Investing Activities | |||||
Capital Expenditures | -899.0K | -242.0K | 271.0K | -102.0K | -900.0K |
Acquisitions | 0 | 0 | -41.5M | 0 | - |
Investment Purchases | -140.0K | -12.0K | -5.0M | -3.1M | -66.0K |
Investment Sales | 0 | 4.6M | 0 | 0 | - |
Investing Cash Flow | -1.0M | 4.3M | -46.3M | -3.3M | -966.0K |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | 0 | 0 | 0 |
Debt Issuance | 0 | 89.0K | 0 | 15.3M | 207.0K |
Debt Repayment | -10.3M | -4.7M | -1.7M | -50.3M | -2.2M |
Financing Cash Flow | -10.6M | -5.1M | -3.8M | -8.9M | -494.0K |
Free Cash Flow | 14.6M | -57.9M | -72.6M | 99.4M | -97.3M |
Net Change in Cash | 3.9M | -55.3M | -122.4M | 89.3M | -100.9M |
Cash Flow Trend
Genfit S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
124.80
Forward P/E
-7.63
Price to Book
2.69
Price to Sales
2.71
Profitability Ratios
Profit Margin
2.13%
Operating Margin
-293.86%
Return on Equity
2.20%
Return on Assets
1.15%
Financial Health
Current Ratio
1.23
Debt to Equity
89.76
Beta
1.28
Per Share Data
EPS (TTM)
€0.03
Book Value per Share
€1.39
Revenue per Share
€1.42
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
gnft | 191.4M | 124.80 | 2.69 | 2.20% | 2.13% | 89.76 |
Abivax SA | 4.6B | -21.14 | -565.33 | -196.12% | 0.00% | -16.16 |
Valneva SE | 857.1M | 70.64 | 4.50 | -38.02% | -34.15% | 105.63 |
Medincell S.A | 584.8M | - | - | 112.65% | -66.50% | -4.11 |
Inventiva S.A | 536.1M | -1.25 | -1.40 | 172.73% | 0.00% | -1.70 |
BNP Paribas Easy | 463.1M | 15.99 | - | -96.39% | -27.22% | 2.22 |
Financial data is updated regularly. All figures are in the company's reporting currency.